Skip to content
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•17 filings

APRE

Aprea Therapeutics, Inc.

No net buying or selling imbalance over the last 3 months

No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 10 CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

$0.00

0 buyers · 0 sellers

12-month purchases

$210,905

4 distinct insiders

12-month sales

$0.00

0 distinct insiders

Highlighted alerts

14

0 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

10 executive purchases found

Get APRE insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

APRE overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

34
Raw transactions
Everything returned by the filing
14
Voluntary view
P/S trades after deterministic checks
20
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
Code
A
Shares
3,135
Price
$0.00
Footnotes
2

These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Raspberry interpretation
Informational — no alert

Reason: administrative_code.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

14 transactions

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
30,978
Price
—
Value
—
Open SEC filing

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
30,978
Price
$0.81
Value
$24,999
Open SEC filing

Peters Richard

Director

PurchaseAlert
Shares
123,915
Price
—
Value
—
Open SEC filing

Peters Richard

Director

PurchaseAlert
Shares
123,915
Price
$0.81
Value
$99,999
Open SEC filing

Gilad Oren

President/CEO

PurchaseAlert
Shares
28,100
Price
$0.89
Value
$25,009
Open SEC filing

Gilad Oren

President/CEO

PurchaseAlert
Shares
28,100
Price
—
Value
—
Open SEC filing

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
5,700
Price
$0.89
Value
$5,073
Open SEC filing

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
5,700
Price
—
Value
—
Open SEC filing

Duey Marc

Director

PurchaseAlert
Shares
21,459
Price
$1.17
Value
$25,000
Open SEC filing

Duey Marc

Director

PurchaseAlert
Shares
21,459
Price
—
Value
—
Open SEC filing

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
5,000
Price
$1.17
Value
$5,825
Open SEC filing

Hamill John P.

SrVP/CFO/Prin Fin & Acct Ofcr

PurchaseAlert
Shares
5,000
Price
—
Value
—
Open SEC filing

Gilad Oren

President/CEO

PurchaseAlert
Shares
21,459
Price
—
Value
—
Open SEC filing

Gilad Oren

President/CEO

PurchaseAlert
Shares
21,459
Price
$1.17
Value
$25,000
Open SEC filing

“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.